Two-week Intensive Outpatient Trauma Treatment.

NCT07565311 | Recruiting DMC

• 1 other identifier: 260225
• Study Type: interventional
• Target: 42
• Locations: 1 country
• Sites: 1

Brief Summary

The objective of the study is to obtain knowledge about the treatment of patients who are offered intensive trauma treatment at Nydalen DPS (NDPS) and Søndre Oslo DPS (SODPS). The treatment takes place on an outpatient basis over two weeks. Up to 42 patients will be recruited. The efficacy of treatment will be investigated using validated self-report forms, which measure PTSD symptoms (PCL-5 and ITQ) and quality of life/function (WHO-5, and WSAS). The measurements will be done before the treatment and one and twelve weeks after treatment.In-depth interviews will also be conducted with up to 30 patients to investigate the outcome and any need for adjustments with focus on patients with minority backgrounds, men and patients with limited benefit. The study uses a mixed methods design, where quantitative measures and information from qualitative interviews are combined to map participants' experience, benefits and feasibility.

Conditions

Posttraumatic Stress Disorder (PTSD)

Keywords

Intensive trauma treatment; qualitative study; EMDR; Prolonged exposure

Outcome Measures

Primary Outcomes (1)

• Trauma symptom score as measured by International Trauma Questionnaire (ITQ)

  ITQ: Higher score equals higher symptom load

  12 weeks

Secondary Outcomes (1)

• Function as measured by Work and social adjustment scale (WSAS)

  12 weeeks

Other Outcomes (1)

• Quality of life as measured by WHO-5, PTSD symptom load as measured by PCL-5

  12 weeks

Study Arms (1)

Intensive trauma treatment

EXPERIMENTAL

Other: Prolonged exposure and EMDR

Interventions

Prolonged exposure and EMDR OTHER

Two-week intensive traume treatment

Also known as: EMDR, prolonged exposure

Intensive trauma treatment

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• PTSD
• years
• Able to give written informed consent.

You may not qualify if:

• Active substance abuse
• psychotic or bipolar disorder
• organic brain disorder
• IQ\< 70
• Currently in a life-threating situation.
• Serious suicide risk.

Sponsors & Collaborators

• Oslo University Hospital: lead

Study Sites (1)

Oslo University Hospital

Oslo, Norway

RECRUITING

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Interventions

Eye Movement Desensitization Reprocessing

Condition Hierarchy (Ancestors)

Stress Disorders, Traumatic; Trauma and Stressor Related Disorders; Mental Disorders

Intervention Hierarchy (Ancestors)

Desensitization, Psychologic; Behavior Therapy; Psychotherapy; Behavioral Disciplines and Activities

Study Officials

• Julie H Evensen, MD PhD

  Oslo University Hospital

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Julie H Evensen, MD PhD

CONTACT

004799339292; uxevej@ous-hf.no

Veronica Vaage-Kowalzik, MD

CONTACT

UXVAAG@ous-hf.no

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal investigator

Study Record Dates

• First Submitted: February 20, 2026
• First Posted: May 4, 2026
• Study Start: January 26, 2026
• Primary Completion (Estimated): December 31, 2027
• Study Completion (Estimated): December 31, 2027
• Last Updated: May 4, 2026

Record last verified: 2026-04

Data Sharing

• IPD Sharing: Will not share

Locations

NO (1)